Macrophage involvement in Epstein-Barr virus-related tumors

Shimakage,Misuzu; Sakamoto,Haruhiko

doi:10.3892/etm_00000044

Macrophage involvement in Epstein-Barr virus-related tumors

Authors:
- Misuzu Shimakage
- Haruhiko Sakamoto
View Affiliations

Affiliations: Department of Pediatrics, National Hospital Organization, Wakayama National Hospital, Wakayama 644-0044, Japan
Published online on: March 1, 2010 https://doi.org/10.3892/etm_00000044
Pages: 285-291

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Epstein-Barr virus (EBV) is known as a causative agent of Burkitt's lymphoma, nasopharyngeal carcinoma and approximately 10% of stomach carcinoma cases. In other human cancers, EBV gene expression including lytic infection protein detected using in situ hybridization and immunofluorescence staining has been reported. Moreover, the expression and replication of EBV genes in cultured normal macrophages and in histiocytes of Langerhans' cell histiocytosis have been identified. The aim of this study was to examine EBV expression in macrophages in other EBV-associated human tumors. Forty-one cases of EBV-associated tumors, which had been confirmed to express EBV, were examined. Tissue sections after in situ hybridization were double-stained immunohistochemically with the monoclonal anti-CD68 antibody. EBV expression in macrophages in the lesions of nasopharyngeal carcinoma, oral cancer, thyroid carcinoma, renal cell carcinoma, testicular carcinoma, uterine carcinoma, cutaneous T-cell lymphoma and anaplastic large-cell lymphoma was identified, whereas macrophages in normal or non-cancerous lesions showed no EBV expression. Many tumor-associated macrophages in EBV-related tumors carry EBV, which appears to induce the EBV lytic infection of macrophages. Therefore, the possibility that the lytic infection of macrophages by EBV and the resulting inflammation play certain roles in the oncogenesis of EBV-associated human tumors was raised.

View Figures

View References

1.	Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
2.	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
3.	IARC World Cancer Report: Chronic Inflammations. IARC Press; Lyon: pp. 56–61. 2003
4.	Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T and Sasagawa T: Association of Epstein-Barr virus with oral cancers. Hum Pathol. 33:608–614. 2002. View Article : Google Scholar : PubMed/NCBI
5.	Shimakage M, Sasagawa T, Yoshino K, Yutsudo M, Kimura M, Yamamoto N and Yanoma S: Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas. Hum Pathol. 30:1071–1076. 1999. View Article : Google Scholar : PubMed/NCBI
6.	Shimakage M, Kawahara K, Sasagawa T, Inoue H, Yutsudo M, Yoshida A and Yanoma S: Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression. Hum Pathol. 34:1170–1177. 2003. View Article : Google Scholar : PubMed/NCBI
7.	Shimakage M, Kawahara K, Harada S, Sasagawa T, Shinka T and Oka T: Expression of Epstein-Barr virus in renal cell carcinoma. Oncol Rep. 18:41–46. 2007.PubMed/NCBI
8.	Shimakage M, Oka T, Shinka T, Kurata A, Sasagawa T and Yutsudo M: Involvement of Epstein-Barr virus expression in testicular tumors. J Urol. 156:253–257. 1996. View Article : Google Scholar : PubMed/NCBI
9.	Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H and Inoue M: Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasm and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Hum Pathol. 31:318–326. 2000. View Article : Google Scholar
10.	Shimakage M and Sasagawa T: Detection of Epstein-Barr virus-determined nuclear antigen-2 mRNA by in situ hybridization. J Virol Methods. 93:23–32. 2001. View Article : Google Scholar : PubMed/NCBI
11.	Shimakage M, Harada S, Kawahara K, Oka T, Yanoma S, Horii K and Sasagawa T: Detection of Epstein-Barr virus nuclear antigen leader protein expression in various human cancers. New Developments in Epstein-Barr Virus Research. Umar CS: Nova Science Publishers; New York: pp. 261–276. 2006
12.	Shimakage M, Dezawa T, Tamura S, Tabata T, Aoyagi N, Koike M, Inoue H, Yutsudo M, Hakura A and Ikegami N: A Ki-1-positive cell line expressing Epstein-Barr virus antigen established from a child with Ki-positive lymphoma. Intervirology. 36:215–224. 1993.PubMed/NCBI
13.	Shimakage M, Nakamine H, Tamura S, Takenaka T, Yutsudo M and Hakura A: Detection of Epstein-Barr virus transcripts in anaplastic large-cell lymphomas by mRNA in situ hybridization. Hum Pathol. 28:1415–1419. 1997. View Article : Google Scholar : PubMed/NCBI
14.	Shimakage M, Sasagawa T, Kawahara K, Yutsudo M, Kusuoka H and Kozuka T: Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides. Int J Cancer. 92:226–231. 2001. View Article : Google Scholar : PubMed/NCBI
15.	Nakajima H, Shimakage M, Takeda Y, Furutama D, Sugino M, Kimura F, Shibayama Y and Hanafusa T: Epstein-Barr virus-associated primary leptomeningeal lymphoma. Eur J Neurol. 13:e4–e6. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Shimakage M, Sakamoto H, Harada S, Sasagawa T and Kodama K: Expression of the Epstein-Barr virus in lymphoproliferative diseases of the lung. Oncol Rep. 17:1347–1352. 2007.PubMed/NCBI
17.	Hoshikawa Y, Satoh Y, Murakami M, Maeta M, Kaibara N, Ito H, Kurata T and Sairenji T: Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carinoma. J Med Virol. 99:351–359. 2002. View Article : Google Scholar : PubMed/NCBI
18.	Takasaka N, Tajima M, Okinaga K, Satoh Y, Hoshikawa Y, Katsumoto T, Kurata T and Sairenji T: Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. Virology. 247:152–159. 1998. View Article : Google Scholar : PubMed/NCBI
19.	Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
20.	Revoltella RP, Vigneti E, Fruscalzo A, Park M, Ragona G, Rocchi G and Calef E: Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell line established from the bone marrow of children with maturation defects of haematopoiesis. J Gen Virol. 70:1203–1215. 1989. View Article : Google Scholar : PubMed/NCBI
21.	Savard M, Belanger C, Tardif M, Gourde P, Flamand L and Gosselin J: Infection of primary human monocytes by Epstein-Barr virus. J Virol. 74:2612–2619. 2000. View Article : Google Scholar : PubMed/NCBI
22.	Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G, Kozuka T, Dezawa T, Tamura S, Ohshima A, Yutsudo M and Hakura A: Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol. 144:157–166. 1999. View Article : Google Scholar : PubMed/NCBI
23.	Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K and Sakamoto H: Expression of Epstein-Barr virus in Langerhans’ cell histiocytosis. Hum Pathol. 35:862–868. 2004.
24.	Shimakage M: Langerhans cell histiocytosis and its relationship with Epstein-Barr virus – reply. Hum Pathol. 37:1509–1511. 2006.
25.	Tierney RJ, Steven N, Young LS and Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells, analysis of viral gene transcription during primary infection and in the carrier state. J Virol. 68:7374–7385. 1994.PubMed/NCBI
26.	Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, Syrjanen KJ and Cunha-Filho JS: Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression – clinicopathological correlation. Gynecol Oncol. 105:157–165. 2007.PubMed/NCBI
27.	Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M and Sato A: Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol. 109:122–128. 2008. View Article : Google Scholar
28.	Hamada I, Kato M, Yamasaki T, Iwabuchi K, Watanabe T, Yamada T, Isoyama S, Ito H and Okada K: Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res. 22:4281–4284. 2002.PubMed/NCBI
29.	Kawanishi S, Hiraku Y, Pinlaor S and Ma N: Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem. 387:365–372. 2006. View Article : Google Scholar : PubMed/NCBI
30.	Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y and Kawanishi S: Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer. 122:2517–2525. 2008. View Article : Google Scholar : PubMed/NCBI
31.	Chayarit P, Ma N, Hiraku Y, Pinlaor S, Yangvanit P, Jintakanon D, Murata M, Oikawa S and Kawanishi S: Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 96:553–559. 2006. View Article : Google Scholar : PubMed/NCBI
32.	Grivel J-C, Ito Y, Faga G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P and Margolis L: Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med. 7:1232–1235. 2001. View Article : Google Scholar : PubMed/NCBI
33.	Lisco A, Grivel JC, Biancotto A, Vanopouille C, Origgi F, Malnati MS, Schols D, Lusso P and Margolis LB: Viral interaction in human lymphoid tissue: human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J Virol. 81:708–717. 2007. View Article : Google Scholar : PubMed/NCBI
34.	Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond D, Miller VL and Virgin HW IV: Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 447:326–330. 2007. View Article : Google Scholar : PubMed/NCBI
35.	Sasagawa T: Human papillomavirus infection and cervical cancer. Biomed Rev. 14:75–93. 2003. View Article : Google Scholar